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1. Introduction 
Neuraminic acid is widely distributed in nature, 
occurring generally as a component of the oligosac- 
charide units of glycoproteins, gangliosides and of 
the milk and urinary oligosaccharides. Increased 
attention has recently been paid to its presence in 
the membranes of normal and malignant cell surfaces. 
Several methods have been developed for the 
determination of neuraminic acid; most of them are 
calorimetric [l-3] . Gas chromatographic [4,5], 
radioisotopic [6] and enzymatic [7] methods have 
also been described. These methods, however, require 
relatively pure samples and estimation of amounts 
under 1 pg from samples of biological origin is often 
difficult. 
In the present work neuraminic acid is determined 
with gas chromatography-mass spectrometry using 
the multiple-ion-detection technique. The compound 
is liberated by methanolysis, re-iV-acetylated and 
trimethylsilylated before gas chromatographic anal- 
ysis. A derivative labelled with deuterium in the 
methyl groups is used as an internal standard. For 
quantitation by mass fragmentography two ions 
(m/e 298 and m/e 420) are recorded, which makes the 
method highly specific. The method allows an 
accurate determination of neuraminic acid from 1 ng 
(3.3 pmdl) up to micrograms. As far as the authors 
are aware, no similar method for the determination of 
a monosaccharide has previously been described. 
The method was applied to the analysis of 
neuraminic acid in a crude protein fraction from rat 
brain. 
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2. Experimental 
N-Acetylneuraminic acid was purchased from the 
Sigma Chemical Company, St. Louis, MO., and tetra- 
deuteromethanol from E. Merck, Darmstadt, BRD. 
All other chemicals used were analytical grade 
commercial products. 
Samples for the assay procedure were prepared as 
described by Bhatti et al. [4]. The sample was 
methanolyzed in 0.5 ml of 0.5 N methanolic HCl 
containing 1 ..S’/o HZ0 at 85°C for 18 h. After neu- 
tralization with silver carbonate (200 mg) the sample 
was re-n/-acetylated with 60 ~1 acetic anhydride for 
6 h. The precipitate was washed twice with methanol, 
the solvent evaporated, and the dry sample was 
trimethylsilylated with trimethylchlorsilane- 
hexamethyldisilazane-pyridine (1: 2: 10, v/v/v). 
The internal standard was prepared from N- 
acetylneuraminic acid in an identical manner but 
using trideuteromethanol instead of methanol and 
was added to the sample after the re-A’-acetylation 
step. 
The crude protein fraction from rat brain [8] was 
prepared as follows: the whole brain of a 3-month 
old male Albino W&tar rat was homogenized in 20 
vol chloroform-methanol (2: 1, v/v) at 4°C. After 
centrifugation (20 000 g, 30 min) the precipitate was 
homogenized in 10 vol chloroform-methanol (1: 2, 
v/v) and centrifuged as before. The lipid-free precip- 
itate was used for neuraminic acid analysis. 
Mass spectra were recorded with a Varian MAT 
CH-7 instrument equipped with a Varian Aerograph 
1700 gas chromatograph and a Spectra System 100 
North-Holland hrhlishirlg Company - A msterdam 
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S computer system. Glass columns (2 m X 2 mm, 
i.d.), filled with 2.2% SE-30 on Gas Chrom Q 
(loo-- 120 mesh) from Applied Science Laboratories 
(State Collage, Pa.) were used at temperatures 
190.-220°C. The ionization voltage was 70 eV. 
Ion intensities were recorded with a Statos 1 
recorder using a time constant of 0.1 set and repeti- 
tive scanning over 10 ions (3 set per scan). The 
amount of neuraminic acid was calculated by com- 
paring the sum of intensities under a gas chromato- 
graphic peak with that of the corresponding ion in 
the spectrum of the internal standard. 
3. Results and discussion 
The mass spectra of the trimethylsilyl ethers of the 
methyl ester methyl glycoside and of the trideutero- 
methyl ester trideuteromethyl glycoside of N-acetyl- 
neuraminic acid are shown in fig. 1. For the assay 
procedure two ions (m/e 298 and m/e 420) were 
selected. The corresponding ions in the mass spectrum 
of the deuterium labelled internal standard were 
m/e 301 and m/e 426. The structures of these 
fragments have been studied by Kamerling et al. [9] 
and are shown in fig. 1. 
The sensitivity and linearity of the method were 
tested using known amounts of IV-acetylneuraminic 
acid (1~ 1200 ng) with three dilutions of internal 
standard (10, 100 and 1000 ng). The ratio of the 
peak areas of ions m/e 298 to m/e 301 and m/e 
420 to m/e 426 are shown in fig.2. The response 
was linear using both ions and the ratio of the inter- 
nal standard to the sample can be varied over a wide 
range without affecting linearity. The limit of detec- 
tion was below 1 ng with the more intense ion m/e 
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Fig.1. Mass spectra of trimethylsilyl derivatives of the methyl ester methyl glycoGde (below) and of the trideuteromcthyl ester 
trideuteromethyl glycoside (above) of N-acctyl-neuraminic acid. 
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Fig.2. Standard CLIWCS for determination of neuraminic acid. Peak arca ratios: m/e 298 to m/e 301 (open circles), m/e 420 to 
426 (closed circles). Internal standards 10, 100 and 1000 ng. Each point reprcscnts the avcragc of 6-8 determinations. 
298. The reproducibility of the method was essen- 
tially the same for samples greater than 10 ng 
(standard deviation of the mean was f 2% for 
replicate samples). The background interference 
(equal to approx. 1 ng of neuraminic acid) was con- 
stant during the elution of the peak and could 
easily be subtracted. This interference, which 
mainly comes from the column and silylation re- 
agents, can probably be further decreased. The use 
of continuous ion monitoring, instead of repetitive 
scanning, should also procedure a considerable 
increase in sensitivity. 
To test the applicability of the method to a crude 
biological preparation, 4 mg of the lipid-free protein 
fraction of rat brain was subjected to methanolysis 
and dilutions of the methanolyzate were assayed 
for neuraminic acid (table 1). There was practically 
no interference from other substances and the 
sensitivity of the assay was the same as with pure 
neuraminic acid. Therefore, in principle, it is possible 
to determine neuraminic acid from 10 pg of wet brain 
tissue. 
The absolute values do not necessarily represent 
the true amount of neuraminic acid in the fraction, 
Table 1 
Neuraminic acid content of a crude protein fraction of rat brain 
Protein fraction Internal standard (ng) Neuraminic acid (ng) 
(pg dry weight) m/e 298/301 m/e 4201426 
300 1000 820 820 
100 500 280 290 
30 100 82 86 
10 50 29 30 
3 10 8.3 
1 7 2.1 
_____.__ 
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since the degree of liberation of neuraminic acid from 
tissues by methanolysis has not been adequately 
studied. The result obtained (0.90 pmol/ 100 mg 
protein) compares, however, well with earlier values 
(0.95 pmol/lOO mg) [8] obtained with gas chromate. 
graphy after more extensive purification. 
A major advantage of the mass spectrometric 
method, besides its sensitivity, is its specificity. This 
specificity arises from the use of an internal standard 
of deuterated neuraminic acid to obtain an accurate 
retention time and the possibility of using several 
ions for quantitation. 
Due to the selectivity of the detection the analysis 
time can be shortened to 3-4 min which further 
increases the usefulness of the method. 
In the present work, methanolysis was applied 
directly to a tissue sample, but other methods of 
liberation could, and probably should, be used to 
degrade membranes and glycoproteins as a prelimi- 
nary step. At present the uncertainty in the pretreat- 
ment of samples for this of other carbohydrate assays 
is far greater than those of the final analytical 
method itself. 
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